Skip to main content
Quest Diagnostics

An HDL Proteomic Score Independently Predicts Incident Atherosclerotic Cardiovascular Disease

An HDL Proteomic Score Independently Predicts Incident Atherosclerotic Cardiovascular Disease

Authors: Melander O, Rohatgi A, Louie JZ, Collier TS, McPhaul MJ, Abbasi F

Citation: JACC Adv. 2025 Jun 25;4(6 Pt 2):101844. doi: 10.1016/j.jacadv.2025.101844.

Specialties:  Cardiology, Endocrinology, Cardiovascular disease

Related content

Publication
Association of MPO Levels With Cardiometabolic Disease Stratified by Atherosclerotic Cardiovascular Risk and Intensity of Therapy in a Workforce Population
Publication
Glycemic Control in Patients with Employer-Sponsored Health Benefits
Audio Podcast
The Cardiometabolic Approach: A Solution to Modern Disease Risk Assessment
Audio Podcast
Instant Insights: Apolipoprotein B
Audio Podcast
From Inflammation to Action: MPO’s Role in Chronic Disease
Test FAQ
ASCVD Risk Panel with Score
Test FAQ
CardioIQ® Insulin Resistance Panel with Score
Test FAQ
Cardio IQ® Lipoprotein Fractionation Ion Mobility

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.